Dimethylarginine dimethylaminohydrolase 2 regulates nitric oxide synthesis and hemodynamics and determines outcome in Polymicrobial sepsis

  • Simon Lambden
  • , Peter Kelly
  • , Blerina Ahmetaj-Shala
  • , Zhen Wang
  • , Benjamin Lee
  • , Manasi Nandi
  • , Belen Torondel
  • , Matthew Delahaye
  • , Laura Dowsett
  • , Sophie Piper
  • , James Tomlinson
  • , Ben Caplin
  • , Lucy Colman
  • , Olga Boruc
  • , Anna Slaviero
  • , Lan Zhao
  • , Eduardo Oliver
  • , Sanjay Khadayate
  • , Mervyn Singer
  • , Francesca Arrigoni
  • James Leiper

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Ddah2 has a regulatory role both in normal physiology and in determining outcome of severe polymicrobial sepsis. Elucidation of this role identifies a mechanism for the observed relationship between Ddah2 polymorphisms, cardiovascular disease, and outcome in sepsis.
    Original languageEnglish
    Pages (from-to)1382-1392
    JournalArteriosclerosis, Thrombosis, and Vascular Biology
    Volume35
    Issue number6
    DOIs
    Publication statusPublished - Jun 2015

    Fingerprint

    Dive into the research topics of 'Dimethylarginine dimethylaminohydrolase 2 regulates nitric oxide synthesis and hemodynamics and determines outcome in Polymicrobial sepsis'. Together they form a unique fingerprint.

    Cite this